OA08.02 DREAM - A Phase 2 Trial of Durvalumab With First Line Chemotherapy in Mesothelioma: Final Result
Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.276
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV